In one paragraphArticle in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Veronica BensaLaboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0000-0002-4927-2731 Hugo Lopes-CardosoCNC-UC-Center for Neurosciences and Cell Biology, Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Rua Larga-Faculdade de Medicina, 1ºandar-POLO I, 3004-504 Coimbra, Portugal.
Martina ArditoLaboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0000-0002-6008-9356 Eleonora CiampiLaboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0009-0003-5044-3184 Anastasiya VoronovskaCNC-UC-Center for Neurosciences and Cell Biology, Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Rua Larga-Faculdade de Medicina, 1ºandar-POLO I, 3004-504 Coimbra, Portugal.ORCID 0000-0002-3354-160X João Soares-GonçalvesCNC-UC-Center for Neurosciences and Cell Biology, Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Rua Larga-Faculdade de Medicina, 1ºandar-POLO I, 3004-504 Coimbra, Portugal.ORCID 0000-0001-5658-3813 Mirco PonzoniLaboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0000-0002-6164-4286 Chiara BrignoleLaboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0000-0002-2563-6991 João Nuno MoreiraCNC-UC-Center for Neurosciences and Cell Biology, Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Rua Larga-Faculdade de Medicina, 1ºandar-POLO I, 3004-504 Coimbra, Portugal.ORCID 0000-0003-3449-0522 Fabio PastorinoLaboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0000-0002-8312-808X Funding
CInTech - Technological Hub for Innovation, Translation and Industrialization of Com-plex Injectable Drugs (PRR-30) , co-funded by Component C5 - Capitalisation and Business Innovation under the Portuguese Resili-ence and Recovery Plan (PRR) C644865576-00000005Italian Association for Cancer Research IG 24397Ministry of Health Ricerca Corrente 2024-2025
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Antineoplastic AgentsCeramidesDoxorubicinLiposomesNanoparticlesNeuroblastomaPhosphoproteinsRNA-Binding ProteinsApoptosisCell Line, TumorHumansNucleolinAntineoplastic AgentsCeramidesDoxorubicinLiposomesNucleolinPhosphoproteinsRNA-Binding Proteinsdrug deliveryliposomesneuroblastomanucleolin
Identifiers
PMID42274551
PMCPMC13257010
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390